Interdigitating Dendritic Cell Sarcoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Interdigitating Dendritic Cell Sarcoma

hematologic malignancy

Identifier: CI-CAN-00001013
Entity page: /cancer/interdigitating-dendritic-cell-sarcoma ↗
Edges: 51

Neighbours: 13 drugs10 trials
Drawn: 23 of 23 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Interdigitating Dendritic Cell Sarcoma investigated in trials for …INVESTIGATED_IN_TRIALSderived13 of 13
→ investigated in trials for	Cyclophosphamidesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Interdigitating Dendritic Cell Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Glofitamabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants

Interdigitating Dendritic Cell Sarcoma studied in …STUDIED_INderived10 of 38show all (up to 200)
→ studied in	NCT07443137Phase 1 · not yet recruiting CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study) · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active)	—	—	Interdigitating Dendritic Cell Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07778212NA · recruiting Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active)	—	—	Interdigitating Dendritic Cell Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07570823Phase 3 · recruiting A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active)	—	—	Interdigitating Dendritic Cell Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03316573Phase 2 · suspended Pembrolizumab in Neoplasms or Lymphomas · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active)	—	—	Interdigitating Dendritic Cell Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07744724Phase 2 · not yet recruiting Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active)	—	—	Interdigitating Dendritic Cell Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07744737Phase 2 · not yet recruiting Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active)	—	—	Interdigitating Dendritic Cell Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07744750Phase 2 · not yet recruiting Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma · condition mapped PROBABILISTIC · 38 trials mapped (34 active)	—	—	Interdigitating Dendritic Cell Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07749365Phase 2 · recruiting Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active)	—	—	Interdigitating Dendritic Cell Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07680933Phase 2 · recruiting Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active)	—	—	Interdigitating Dendritic Cell Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07677813Phase 2 · not yet recruiting Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active)	—	—	Interdigitating Dendritic Cell Sarcoma	1	Observed	clinicaltrials	graph →